Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS

Non-small-cell lung cancer (NSCLC) constitutes approximately 80% of all diagnosed lung cancers, and diagnostic markers detectable in the plasma/serum of NSCLC patients are greatly needed. In this study, we established a pipeline for the discovery of markers using 9 transcriptome datasets from public...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Jihye, Song, Sang-Yun, Ahn, Hee-Sung, An, Byung Chull, Choi, Yoo-Duk, Yang, Eun Gyeong, Na, Kook-Joo, Lee, Seung-Taek, Park, Jae-Il, Kim, Seon-Young, Lee, Cheolju, Lee, Seung-won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570484/
https://www.ncbi.nlm.nih.gov/pubmed/28837649
http://dx.doi.org/10.1371/journal.pone.0183896

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570484/
https://www.ncbi.nlm.nih.gov/pubmed/28837649
http://dx.doi.org/10.1371/journal.pone.0183896

Ejemplares similares